Stock Events

Novo Nordisk A/S 

kr834.1
583
+kr0.2+0.02% Today

Statistics

Day High
842.6
Day Low
827
52W High
861.5
52W Low
476.05
Volume
1,584,121
Avg. Volume
2,635,850
Mkt Cap
3.79T
P/E Ratio
45.67
Dividend Yield
1.49%
Dividend
12.4

Upcoming

Dividends

1.49%Dividend Yield
10Y Growth
-2.38%
5Y Growth
12.51%
3Y Growth
18.06%
1Y Growth
26.91%

Earnings

2MayExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
0
2.11
4.23
6.34
Expected EPS
0.814
Actual EPS
0

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NOVO-B.CO. It's not an investment recommendation.

About

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Show more...
CEO
Mr. Lars Fruergaard Jorgensen
Employees
63370
Country
DK
ISIN
DK0060534915
WKN
000A1XA8R

Listings